The Quotient™ ADHD System1 is the first FDA-cleared2 test that offers healthcare professionals an office-based capability to conduct rapid, precise and objective patient assessments that aid in the diagnosis of ADHD. The Quotient™ ADHD System offers healthcare professionals a novel and systematic method to precisely measure the core symptoms of ADHD:
- Hyperactivity (inability to control movement and sit still while working)
- Inattention (difficulty in staying focused and on task)
- Impulsivity (inability to inhibit inappropriate responses)
Simple Design, Quick Answers
The Quotient™ ADHD System fits neatly into any office setting. The 15 to 20-minute test is designed to be a non-invasive well-controlled and reproducible office-based test that replicates a patient’s classroom or work environment.
Data captured by the Quotient™ ADHD System Test is sent instantly from the clinician’s office, securely via the internet, to BioBDx’s central server for analysis. Analysis results in the form of a Patient Report are immediately available via a secure web access. The simple to read intuitive patient report illustrates the captured behavior of the patient using 19 measurements of the core symptoms of ADHD, in a comparative format to non-ADHD subjects at the same development stage (i.e., age, gender and grade) who took the identical Quotient™ ADHD System Test.
1. The Quotient™ ADHD System was formerly known as the MMAT/ADHD™ System.
2. FDA clearance of this product does not in any way denote FDA approval of the device.
Reliable Data – The Patient Report